LabTurbo Biotech (7725.TWO) Stock Price

LabTurbo Biotech Price

CLOSED
23.00
​
Market closed

Revenue at LabTurbo Biotech has contracted by 58.0% per year over the past 3 years to 72.49 M TWD. Earnings per share have declined at 69.5% per year over the last 3 years. LabTurbo Biotech's net margin stands at 17.9%, down from 46.8% several years earlier. LabTurbo Biotech currently offers a dividend yield of about 2.19%. The payout ratio is around 186% of earnings.

LabTurbo Biotech stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

LabTurbo Biotech business model & stock analysis

LabTurbo Biotech Corp is a TW-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Taipei City, Taipei. The company went IPO on 2023-12-22. LabTurbo Biotech Corp is a Taiwan-based company that specializes in fully automated precision medical genetic testing systems and reagent kits, as well as testing services. The firm's products include LabTurbo AIO, a fully automated nucleic acid extraction genetic testing device, nucleic acid extraction reagents, and multi-specimen genetic testing reagents. The firm provides testing services. The firm is also engaged in the operation of sports science centers. The firm sells its products both domestically and internationally.

Frequently asked questions about LabTurbo Biotech

Converted at the current exchange rate, the LabTurbo Biotech share trades at 0.63 EUR (23.00 TWD).

The revenue cannot currently be calculated for LabTurbo Biotech.

The profit cannot currently be calculated for LabTurbo Biotech.

The P/E ratio cannot be calculated for LabTurbo Biotech at the moment.

The P/S cannot be calculated for LabTurbo Biotech currently.

The Eulerpool Quality Score for LabTurbo Biotech is 1/10.

The ISIN of LabTurbo Biotech is TW0007725004. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of LabTurbo Biotech is 7725.TWO. The ticker symbol is used to trade LabTurbo Biotech shares on the stock exchange.

Fair ValueTerminal
21.16 TWD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Equipment & Supplies
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Taiwan
Currency
TWD
Initial public offering
Dec 22, 2023
ISIN
TW0007725004
Cusip
Y50754103
Market capitalization
1.11 B TWDSmall Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/Se
—
EV/EBIT
—
P/B Ratio
0.85
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
0.97 %
Dividend
Dividend yield
2.19 %
Payout Ratio
186.40 %
Dividend growth Ø5Y
—
Dividend payments per year
1
Dividend paid since
2 years
Dividend not reduced since
0 years
Dividend increased since
0 years
Dividend withholding tax
21.00 %
Last updated Oct 20, 2026, 11:35 PM

LabTurbo Biotech Peer Group